Clonal Heterogeneity in the 5q- Syndrome: P53 Expressing Progenitors Prevail During Lenalidomide Treatment and Expand at Disease Progression
Haematologica - Italy
doi 10.3324/haematol.2009.011528
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2009
Authors
Publisher
Ferrata Storti Foundation (Haematologica)